Literature DB >> 20697810

Efficient production of recombinant IgG by metabolic control and co-expression with GLUT5 in a fructose-based medium.

Yuichi Inoue1, Yuriko Tsukamoto, Makoto Yamanaka, Shigeki Nakamura, Aiko Inoue, Norikazu Nishino, Hiroharu Kawahara.   

Abstract

A fructose-based cell culture is suitable for the process control of protein production because of slow sugar consumption rate and low lactate accumulation. The fructose transporter, GLUT5, mediates its incorporation into cells and is required for the fructose-based culture. In order to produce efficiently recombinant IgG by metabolic control and co-expression with GLUT5 in a fructose-based medium, an IgG and GLUT5 co-expression vector was constructed and transfected into the human myeloma derived cell line, SC-01MFP, which produced stably recombinant proteins. The cell proliferation in the fructose-based medium was improved by the GLUT5 gene transfection. The recombinant IgG production of the cells cultured in the fructose-based medium exhibited about two-fold increase of that in the glucose-based medium. Flow cytometoric analysis indicated that the GLUT5 protein expression level in cell surface was increased in the fructose-based medium. An exogenous but not endogenous GLUT5 transcription activator remarkably raised IgG productivity in the fructose-based medium when compared to that in the glucose-based medium, suggesting that exogenous GLUT5 expression may be involved in it. The GLUT5 co-expression system may be useful for efficient production of recombinant proteins by the fructose-based cell culture.

Entities:  

Year:  2010        PMID: 20697810      PMCID: PMC2978310          DOI: 10.1007/s10616-010-9289-6

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  11 in total

1.  Class-switching of the IgM type anti-adenocarcinoma human antibody HB4C5 into an IgG1 type resulted in the loss of the antigen binding ability.

Authors:  H Haruta; H Tachibana; K Mochizuki; S Hashizume; K Kusakabe; S Shirahata; H Murakami
Journal:  Hum Antibodies       Date:  1997

2.  The effect of alternative carbohydrates on the growth and antibody production of a murine hybridoma.

Authors:  D Petch; M Butler
Journal:  Appl Biochem Biotechnol       Date:  1996-04       Impact factor: 2.926

3.  Enhanced production of human monoclonal antibodies by the use of fructose in serum-free hybridoma culture media.

Authors:  K Mochizuki; S Sato; M Kato; S Hashizume
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

4.  Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6).

Authors:  T Kayano; C F Burant; H Fukumoto; G W Gould; Y S Fan; R L Eddy; M G Byers; T B Shows; S Seino; G I Bell
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

5.  Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations.

Authors:  K Low; C Harbour
Journal:  Dev Biol Stand       Date:  1985

6.  Transgene expression enhancement in T-lymphoma cell lines.

Authors:  Paula Ruybal; María José Gravisaco; Virna Barcala; Ana Escalada; Graciela Cremaschi; Oscar Taboga; Claudia Waldner; Claudia Mongini
Journal:  Int Immunopharmacol       Date:  2005-11       Impact factor: 4.932

7.  Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients.

Authors:  M Shoji; S Kawamoto; S Sato; M Kamei; M Kato; S Hashizume; K Seki; K Yasumoto; A Nagashima; H Nakahashi
Journal:  Hum Antibodies Hybridomas       Date:  1994

8.  Changes of monosaccharide availability of human hybridoma lead to alteration of biological properties of human monoclonal antibody.

Authors:  H Tachibana; K Taniguchi; Y Ushio; K Teruya; K Osada; H Murakami
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

9.  Engineering cell metabolism for high-density cell culture via manipulation of sugar transport.

Authors:  Katie F Wlaschin; Wei-Shou Hu
Journal:  J Biotechnol       Date:  2007-06-23       Impact factor: 3.307

Review 10.  Regulation of the fructose transporter GLUT5 in health and disease.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-08       Impact factor: 4.310

View more
  4 in total

1.  Efficient production of recombinant IgG by the GLUT5 co-expression system.

Authors:  Yuichi Inoue; Aiko Inoue; Hiroharu Kawahara
Journal:  BMC Proc       Date:  2011-11-22

2.  Improvements in protein production in mammalian cells from targeted metabolic engineering.

Authors:  Anne Richelle; Nathan E Lewis
Journal:  Curr Opin Syst Biol       Date:  2017-06-06

3.  Nucleofection of whole murine retinas.

Authors:  Iria Maria Gomez-Touriño; Ana Senra; Francisco Garcia
Journal:  Cytotechnology       Date:  2012-11-07       Impact factor: 2.058

4.  Comparative metabolic analysis of CHO cell clones obtained through cell engineering, for IgG productivity, growth and cell longevity.

Authors:  Camila A Wilkens; Ziomara P Gerdtzen
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.